el Mestikawy S, Fargin A, Raymond J R, Gozlan H, Hnatowich M
INSERM U288, Neurobiologie cellulaire et fonctionnelle, Faculté de Médecine Pitié-Salpêtrière, Paris, France.
Neurochem Res. 1991 Jan;16(1):1-10. doi: 10.1007/BF00965820.
Progress in the field of neuronal receptor research has accelerated during the last few years due to developments in pharmacology and molecular biology. This is particularly true in the case of the serotonin 5-HT1A receptor. In 1983 the very selective, high affinity 5-HT1A agonist 8-OH-DPAT was developed which allowed the pharmacology and distribution of the 5-HT1A receptor in the central nervous system of the rat and man to be extensively characterized. By 1987, the gene encoding this receptor protein was cloned and sequenced, allowing not only elucidation of its structure, but also better insight into the nature of its coupling to transmembrane signal transduction systems. Thus in a short period of time considerable knowledge has accumulated on how serotonin exerts its functions in the central nervous system via the 5-HT1A receptor. In the present review we will briefly discuss some of the latest developments regarding the 5-HT1A receptor.
由于药理学和分子生物学的发展,神经元受体研究领域在过去几年中取得了加速进展。血清素5-HT1A受体的情况尤其如此。1983年,研发出了极具选择性、高亲和力的5-HT1A激动剂8-OH-DPAT,这使得大鼠和人类中枢神经系统中5-HT1A受体的药理学和分布得以广泛表征。到1987年,编码该受体蛋白的基因被克隆并测序,这不仅能够阐明其结构,还能更深入地了解其与跨膜信号转导系统偶联的本质。因此,在短时间内,关于血清素如何通过5-HT1A受体在中枢神经系统中发挥作用,已经积累了相当多的知识。在本综述中,我们将简要讨论有关5-HT1A受体的一些最新进展。